Clinical Trial Update: Safety and Efficacy of RK0202 in Oral Mucositis [Phase 2]

View source ↗

Summary

Phase 2 trial of RK0202 for oral mucositis reported safety and preliminary efficacy signals; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• RK0202

Snippet

Sponsor: RxKinetix | Conditions: Mouth Diseases, Mouth Ulcers | Phase 2 | Status: COMPLETED